News item on colorectal cancer drugs now and in develoopment for tomorrow:
coloCan
CSN Member Posts: 1,944 Member
"There are today 270 (234) companies plus partners developing 330 (270) drugs targeting colorectal cancer in active development......" according to a "businesswire.com" article dated 2/8, entitled :"Research and Markets:Colorectal Cancer Drug Pipeline Update 2010...." which is basically a CD-ROM that I think researchers/corportations utilize....Still, they're saying there are 330 drugs this year (270 last year) being worked on to fight colorectal cancer......While we';ve only heard of the more common (5FU,Camptosar,Eloxatan,Avastin,Erbitux,) it seems perhaps there's quite a bit of hope to be had.........Steve
0
Comments
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 122.3K Cancer specific
- 2.8K Anal Cancer
- 451 Bladder Cancer
- 310 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 399 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.4K Kidney Cancer
- 678 Leukemia
- 799 Liver Cancer
- 4.2K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 240 Multiple Myeloma
- 7.2K Ovarian Cancer
- 66 Pancreatic Cancer
- 493 Peritoneal Cancer
- 5.6K Prostate Cancer
- 1.2K Rare and Other Cancers
- 544 Sarcoma
- 740 Skin Cancer
- 659 Stomach Cancer
- 192 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.9K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards